المساهمون: Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit, Byoung C Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young-Chul Kim, Christos S Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E Gray, Luis Paz-Ares, Javier de Castro Carpeño, Corinne Faivre-Finn, Martin Reck, Johan Vansteenkiste, David R Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A Dennis, Mustafa Özgüroğlu, PACIFIC Investigators, Cho, Byoung Chul

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal / administration & dosage, Monoclonal / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / mortality, Non-Small-Cell Lung / radiotherapy, Chemoradiotherapy, Female, Humans, Infusions, Intravenous, Intention to Treat Analysis, Kaplan-Meier Estimate, Lung Neoplasms / drug therapy, Lung Neoplasms / mortality, Lung Neoplasms / radiotherapy, Male, Middle Aged, Survival Rate

العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2022-02149; https://ir.ymlib.yonsei.ac.kr/handle/22282913/188947Test; T999201837; NEW ENGLAND JOURNAL OF MEDICINE, Vol.379(24) : 2342-2350, 2018-12

الإتاحة: https://doi.org/10.1056/NEJMoa1809697Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/188947Test

المؤلفون: Glintborg, Bente, Gudbjornsson, Bjorn, Steen Krogh, Niels, Omerovic, Emina, Manilo, Natalia, Holland-Fischer, Mette, Lindegaard, Hanne M, Gitte Loft, Anne, Nordin, Henrik, Johnsen, Laura, Flejsborg Oeftiger, Sussi, Hansen, Annette, Rasmussen, Claus, Grondal, Gerdur, Jon Geirsson, Arni, Lund Hetland, Merete

المساهمون: Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. glintborg@dadlnet.dk. 2Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 4Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

مصطلحات موضوعية: Sóríasis, Lyfjagjöf, Arthritis, Psoriatic/drug therapy, Antirheumatic Agents/therapeutic use, Denmark, Iceland, Registries, Treatment Outcome, Adult, Antibodies, Monoclonal/administration & dosage, Antirheumatic Agents/administration & dosage, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Infusions, Intravenous, Male, Middle Aged, Prospective Studies, Tumor Necrosis Factor-alpha/antagonists & inhibitors

العلاقة: http://dx.doi.org/10.1093/rheumatology/keu252Test; Rheumatology (Oxford) 2014; http://hdl.handle.net/2336/326075Test; Rheumatology (Oxford, England)

الإتاحة: https://doi.org/10.1093/rheumatology/keu252Test
http://hdl.handle.net/2336/326075Test

المؤلفون: Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, De Keyser, Filip

المساهمون: UCL - (SLuc) Service de rhumatologie, UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales

المصدر: Arthritis Research & Therapy, Vol. 12, no. 3, p. R77 (2010)

مصطلحات موضوعية: Antibodies, Monoclonal - administration & dosage, adverse effects, therapeutic use, Antirheumatic Agents - administration & dosage, Infusions, Intravenous, Kaplan-Meier Estimate, Longitudinal Studies, Male, Methotrexate - therapeutic use, Middle Aged, Severity of Illness Index, Treatment Outcome, Arthritis, Rheumatoid - drug therapy, Belgium, Disease Progression, Drug Therapy, Combination, Female, Follow-Up Studies, Health Surveys, Humans

العلاقة: boreal:105553; http://hdl.handle.net/2078.1/105553Test; info:pmid/20459619; urn:ISSN:1478-6354; urn:EISSN:1478-6362

الإتاحة: https://doi.org/10.1186/ar2997Test
http://hdl.handle.net/2078.1/105553Test

المؤلفون: Raoul, Jean-Luc, Van Laethem, Jean-Luc, Peeters, Marc, Brezault, Catherine, Husseini, Fares, Cals, Laurent, Nippgen, Johannes, Loos, Anja-Helena, Rougier, Philippe

المصدر: BMC cancer, 9

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Adult, Aged, Antibodies, Monoclonal -- administration & dosage -- adverse effects, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, Camptothecin -- administration & dosage -- adverse effects -- analogs & derivatives, Colorectal Neoplasms -- drug therapy -- pathology, Diarrhea -- chemically induced, Disease Progression, Dose-Response Relationship, Drug, Drug Administration Schedule, Exanthema -- chemically induced, Female, Fluorouracil -- administration & dosage -- adverse effects, Follow-Up Studies, Humans, Infusions, Intravenous, Leucovorin -- administration & dosage -- adverse effects, Leukopenia -- chemically induced, Male, Middle Aged, Neoplasm Metastasis, Survival Analysis, Treatment Outcome, Vomiting -- chemically induced

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1186/1471-2407-9-112; uri/info:pii/1471-2407-9-112; uri/info:pmid/19366444; uri/info:scp/65649086838; uri/info:pmcid/PMC2678147; https://dipot.ulb.ac.be/dspace/bitstream/2013/111401/4/doi_91656.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111401Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111401Test

المؤلفون: Antonia, Scott J., Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Kurata, Takayasu, Chiappori, Alberto, Lee, Ki H., de Wit, Maike, Cho, Byoung C., Bourhaba, Maryam, Quantin, Xavier, Tokito, Takaaki, Mekhail, Tarek, Planchard, David, Kim, Young-Chul, Karapetis, Christos S., Hiret, Sandrine, Ostoros, Gyula, Kubota, Kaoru, Gray, Jhanelle E., Paz-Ares, Luis, de Castro Carpeno, Javier, Faivre-Finn, Corinne, Reck, Martin, Vansteenkiste, Johan, Spigel, David R., Wadsworth, Catherine, Melillo, Giovanni, Taboada, Maria, Dennis, Phillip A., Ozguroglu, Mustafa

المصدر: New England Journal of Medicine, 379 (24), 2342-2350 (2018)

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal/administration & dosage/adverse effects, Antineoplastic Agents, Immunological/administration & dosage/adverse effects, Carcinoma, Non-Small-Cell Lung/drug therapy/mortality/radiotherapy, Chemoradiotherapy, Female, Humans, Infusions, Intravenous, Intention to Treat Analysis, Kaplan-Meier Estimate, Lung Neoplasms/drug therapy/mortality/radiotherapy, Male, Middle Aged, Survival Rate, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie

العلاقة: urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/233205Test; info:hdl:2268/233205; scopus-id:2-s2.0-85057249937; info:pmid:30280658

الإتاحة: https://doi.org/10.1056/NEJMoa1809697Test
https://orbi.uliege.be/handle/2268/233205Test

المؤلفون: Moreau, Philippe, van de Donk, Niels W C J, San Miguel, Jesus, Lokhorst, Henk, Nahi, Hareth, Ben-Yehuda, Dina, Cavo, Michele, Cook, Gordon, Delforge, Michel, Einsele, Hermann, Zweegman, Sonja, Ludwig, Heinz, Driessen, Christoph, Palumbo, Antonio, Facon, Thierry, Plesner, Torben, Dimopoulos, Meletios, Sondergeld, Pia, Sonneveld, Pieter, Mateos, María-Victoria

المصدر: Moreau , P , van de Donk , N W C J , San Miguel , J , Lokhorst , H , Nahi , H , Ben-Yehuda , D , Cavo , M , Cook , G , Delforge , M , Einsele , H , Zweegman , S , Ludwig , H , Driessen , C , Palumbo , A , Facon , T , Plesner , T , Dimopoulos , M , Sondergeld , P , Sonneveld , P & Mateos , M-V 2016 , ' Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal ....

مصطلحات موضوعية: ADP-ribosyl Cyclase 1/immunology, Antibodies, Monoclonal/administration & dosage, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Clinical Trials as Topic, Humans, Immunotherapy, Infusions, Intravenous, Multiple Myeloma/drug therapy

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/234ec95c-52bc-4c5f-b47b-b8ad35f478bcTest

الإتاحة: https://doi.org/10.1007/s40265-016-0573-4Test
https://portal.findresearcher.sdu.dk/da/publications/234ec95c-52bc-4c5f-b47b-b8ad35f478bcTest

المؤلفون: Sinnaeve, Peter R, Alexander, John H, Bogaerts, Kris, Belmans, Ann, Wallentin, Lars, Armstrong, Paul, Adgey, Jennifer A A, Tendera, Michal, Diaz, Rafael, Soares-Piegas, Leopoldo, Vahanian, Alec, Granger, Christopher B, Van De Werf, Frans J

المصدر: Am Heart J. 147(6):993-8

مصطلحات موضوعية: Aged, 80 and over, Antibodies, Monoclonal/*administration & dosage, Aspirin/administration & dosage, Drug Administration Schedule, Drug Therapy, Combination, Enoxaparin/*administration & dosage, Female, Fibrinolytic Agents/therapeutic use, Follow-Up Studies, Heparin/administration & dosage/*analogs & derivatives, Humans, Immunoglobulins, Fab/*administration & dosage, Infusions, Intravenous, Injections, Subcutaneous, Male, Middle Aged, Myocardial Infarction/*drug therapy/mortality, Research Support, Non-U.S. Gov't, Survival Rate, Tissue Plasminogen Activator/*administration & dosage

وصف الملف: print

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-71877Test
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15199346&dopt=CitationTest

المؤلفون: Wallentin, Lars, Bergstrand, Lott, Dellborg, Mikael, Fellenius, Carin, Granger, Christopher B, Lindahl, Bertil, Lins, Lars Eric, Nilsson, Tage, Pehrsson, Kenneth, Siegbahn, Agneta, Swahn, Eva

المصدر: Eur Heart J. 24(10):897-908

مصطلحات موضوعية: Administration, Cutaneous, Aged, Antibodies, Monoclonal/administration & dosage, Anticoagulants/*administration & dosage, Aspirin/administration & dosage, Blood Flow Velocity, Chemotherapy, Adjuvant, Comparative Study, Coronary Angiography, Drug Therapy, Combination, Female, Heparin/*administration & dosage, Heparin, Low-Molecular-Weight/administration & dosage, Humans, Immunoglobulins, Fab/administration & dosage, Infusions, Intravenous, Male, Myocardial Infarction/*drug therapy, Myocardial Revascularization, Platelet Aggregation Inhibitors/administration & dosage, Recurrence, Research Support, Non-U.S. Gov't, Tedelparin/administration & dosage, Tissue Plasminogen Activator/*administration & dosage, Treatment Outcome, Vascular Patency

وصف الملف: print

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-71858Test
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12714021&dopt=CitationTest

المؤلفون: Schöffski, Patrick, Garcia, Jorge A, Stadler, Walter M, Gil, Thierry, Jonasch, Eric, Tagawa, Scott T, Smitt, Melanie, Yang, Xin, Oliner, Kelly S, Anderson, Abraham, Zhu, Minghua, Kabbinavar, Fairooz

المصدر: BJU international, 108 (5

مصطلحات موضوعية: Cancérologie, Adult, Aged, 80 and over, Antibodies, Monoclonal -- administration & dosage -- adverse effects -- therapeutic use, Antineoplastic Agents -- administration & dosage -- adverse effects -- therapeutic use, Carcinoma, Renal Cell -- drug therapy -- mortality -- secondary, Dose-Response Relationship, Drug, Female, Hepatocyte Growth Factor -- blood, Humans, Infusions, Intravenous, Kidney Neoplasms -- drug therapy -- mortality -- secondary, Male, Middle Aged, Survival Analysis, Treatment Outcome, Tumor Markers, Biological -- blood, AMG 102, c-Met, clear cell renal cell carcinoma, hepatocyte growth factor, papillary renal cell carcinoma, renal cell carcinoma

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1111/j.1464-410X.2010.09947.x; uri/info:pmid/21156020; uri/info:scp/80051991655; https://dipot.ulb.ac.be/dspace/bitstream/2013/126340/3/126340.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/126340Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/126340Test
https://dipot.ulb.ac.be/dspace/bitstream/2013/126340/3/126340.pdfTest

المؤلفون: Douillard, Jean-Yves, Siena, Salvatore, Cassidy, James, Tabernero, Josep, Burkes, Ronald, Barugel, Mario, Humblet, Yves, Bodoky, György, Cunningham, David, Jassem, Jacek, Rivera, Fernando, Kocákova, Ilona, Ruff, Paul, BÅ‚asiÅ„ska-Morawiec, Maria, Å makal, Martin, Canon, Jean-Luc, Rother, Mark, Oliner, Kelly S, Wolf, Michael, Gansert, Jennifer

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale

المصدر: Journal of Clinical Oncology, Vol. 28, no. 31, p. 4697-4705 (2010)

مصطلحات موضوعية: Adult, Aged, Fluorouracil - administration & dosage, adverse effects, Gene Expression Regulation, Neoplastic, Humans, Infusions, Intravenous, Kaplan-Meier Estimate, Leucovorin - administration & dosage, Male, Middle Aged, Mutation, Neoplasm Staging, 80 and over, Organoplatinum Compounds - administration & dosage, Predictive Value of Tests, Prospective Studies, Proto-Oncogene Proteins - genetics, Receptor, Epidermal Growth Factor - antagonists & inhibitors, Treatment Outcome, Tumor Markers, Biological - genetics, ras Proteins - genetics, Antibodies, Monoclonal - administration & dosage, therapeutic use, Antineoplastic Combined Chemotherapy Protocols - administration & dosage

العلاقة: boreal:87845; http://hdl.handle.net/2078.1/87845Test; info:pmid/20921465; urn:ISSN:0732-183X; urn:EISSN:1527-7755

الإتاحة: https://doi.org/10.1200/JCO.2009.27.4860Test
http://hdl.handle.net/2078.1/87845Test